» Articles » PMID: 36065528

The Deleterious Effects of Anabolic Androgenic Steroid Abuse on Sexual and Reproductive Health and Comparison of Recovery Between Treated and Untreated Patients: Single-center Prospective Randomized Study

Overview
Journal Andrologia
Date 2022 Sep 6
PMID 36065528
Authors
Affiliations
Soon will be listed here.
Abstract

Anabolic androgenic steroids (AAS) abuse is a global health-related concern, as most of the related studies showed increasing trends and deleterious effects, mostly on sexual and fertility health. Unfortunately, there are no consensuses about the management pathways due to the lack of specific guidelines. We aimed to confirm the deleterious effects of AAS abuse, monitor the spontaneous recovery, and demonstrate the effects of treatment regimens on recovery. We enrolled 520 patients with a confirmed history of AAS intake within 1 year of presentation and evaluated their symptoms, hormones levels, and semen every 3 months until 12 months. All patients were monitored for spontaneous recovery in the first 3 months; if they showed no recovery, they were randomized to undergo either continued observation or commence medications. The most common presentation (84%) was a combination of sexual symptoms while some patients (18%) were infertile. Most patients (90%) reported low levels of luteinizing hormone, follicle-stimulating hormone, and total testosterone. After the 3-month observation, most patients (89%) started treatment, but some (11%) continued observation only. Treated patients showed faster improvement regarding the International Index of Erectile Function (IIEF) values, hormone levels, testicular size and semen parameters compared to non-treated patients (p < 0.005). Among the 94 patients who presented with infertility (18%), 61 had oligospermia and 33 had azoospermia. All received treatment, but only 14 (15%) achieved successful pregnancy at 12 months while all azoospermic's patients continued to have infertility at the end of the follow-up period. These findings demonstrated the significant negative impact of AAS abuse on sexual health and fertility, and the need for medical treatment to have faster recovery from their adverse effect.

Citing Articles

Illegal Use of Testosterone and Other Anabolic-Androgenic Steroids in the Population of Amateur Athletes in Wrocław, Poland-An Unfavorable Lifestyle Trend in the Population of Men of Reproductive Age.

Skrzypiec-Spring M, Pokrywka A, Bombala W, Berezovska D, Rozmus J, Brawanska K J Clin Med. 2024; 13(13).

PMID: 38999285 PMC: 11242149. DOI: 10.3390/jcm13133719.


Abusive use of anabolic androgenic steroids, male sexual dysfunction and infertility: an updated review.

Azevedo R, Gualano B, Teixeira T, Nascimento B, Hallak J Front Toxicol. 2024; 6:1379272.

PMID: 38711907 PMC: 11070513. DOI: 10.3389/ftox.2024.1379272.


Use of Anabolic-Androgenic Steroids and Male Fertility: A Systematic Review and Meta-analysis.

Mulawkar P, Maheshwari P, Gauhar V, Agrawal S, Mohammed T, Singh A J Hum Reprod Sci. 2024; 16(4):268-285.

PMID: 38322636 PMC: 10841926. DOI: 10.4103/jhrs.jhrs_90_23.


The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men.

Grant B, Kean J, Vali N, Campbell J, Maden L, Bijral P Subst Abuse Treat Prev Policy. 2023; 18(1):66.

PMID: 37951896 PMC: 10640727. DOI: 10.1186/s13011-023-00573-8.


Fertility outcomes in men with prior history of anabolic steroid use.

Ledesma B, Weber A, Venigalla G, Muthigi A, Thomas J, Narasimman M Fertil Steril. 2023; 120(6):1203-1209.

PMID: 37769866 PMC: 10841476. DOI: 10.1016/j.fertnstert.2023.09.016.


References
1.
Ahmed M, Al-Saud N, Omar A, Magadmi R, Hassan S, Al-Qudsi F . Knowledge of and Attitudes Toward the Use of Anabolic-Androgenic Steroids among the Population of Jeddah, Saudi Arabia. J Microsc Ultrastruct. 2019; 7(2):78-83. PMC: 6585479. DOI: 10.4103/JMAU.JMAU_64_18. View

2.
Rasmussen J, Selmer C, Ostergren P, Pedersen K, Schou M, Gustafsson F . Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study. PLoS One. 2016; 11(8):e0161208. PMC: 4988681. DOI: 10.1371/journal.pone.0161208. View

3.
McBride J, Coward R . Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use. Asian J Androl. 2016; 18(3):373-80. PMC: 4854084. DOI: 10.4103/1008-682X.173938. View

4.
Pany S, Panigrahi S, Rao E, Patnaik L, Sahu T . Anabolic Androgenic Steroid Abuse and their Health Impacts: A Cross-sectional Study among Body Builders in a City of Eastern India. Int J Prev Med. 2020; 10:178. PMC: 6826677. DOI: 10.4103/ijpvm.IJPVM_524_17. View

5.
Kohn T, Louis M, Pickett S, Lindgren M, Kohn J, Pastuszak A . Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy. Fertil Steril. 2016; 107(2):351-357.e1. PMC: 5292276. DOI: 10.1016/j.fertnstert.2016.10.004. View